U.S. Urinary Catheters Market (By Product Type: Intermittent Catheters, Foley/Indwelling Catheters, External Catheters; By Application) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The U.S. urinary catheters market size was estimated at around USD 1.68 billion in 2023 and it is projected to hit around USD 2.68 billion by 2033, growing at a CAGR of 4.79% from 2024 to 2033.

Key Pointers

• By Product Type, the intermittent catheters segment held the largest revenue share of 56% in 2023.
• By Product Type, the external catheters are projected to experience the most rapid growth from 2024 to 2033.
• By Application, the urinary incontinence segment generated the maximum market share 39% in 2023.

U.S. Urinary Catheters Market Overview

The U.S. urinary catheters market is a critical segment within the medical device industry, catering to the needs of millions of patients suffering from various urological conditions. Urinary catheters play a pivotal role in managing urinary retention, incontinence, and facilitating urine drainage, thereby improving patients' quality of life.

U.S. Urinary Catheters Market Growth Factors

The growth of the U.S. urinary catheters market is propelled by several key factors. Firstly, the increasing prevalence of urological disorders, particularly among the aging population, drives the demand for urinary catheters. Technological advancements, such as the development of catheters with enhanced comfort and reduced infection risk, also contribute significantly to market growth. Moreover, the rising healthcare expenditure in the U.S. enables patients to access advanced medical treatments, including urinary catheterization. Regulatory standards play a crucial role in maintaining product quality and safety, fostering consumer trust and market expansion. Additionally, the growing adoption of urinary catheters across various healthcare settings, including hospitals, clinics, and home care, further stimulates market growth. Overall, a combination of demographic trends, technological innovation, regulatory compliance, and healthcare infrastructure development sustains the upward trajectory of the U.S. urinary catheters market.

U.S. Urinary Catheters Market Trends:

• Rising Demand: Increased prevalence of urological disorders, coupled with a growing aging population, fuels the demand for urinary catheters in the U.S.
• Shift towards Minimally Invasive Procedures: A trend towards minimally invasive procedures drives the adoption of intermittent catheters and other less invasive urinary catheterization techniques.
• Preference for Hydrophilic Coatings: Hydrophilic-coated catheters gain traction due to their ability to reduce friction during insertion and removal, enhancing patient comfort and reducing the risk of urethral trauma.
• Growing Home Healthcare Segment: With an increasing emphasis on home-based care, there is a rising demand for urinary catheters suitable for self-catheterization, leading to the development of user-friendly and discreet catheterization solutions.
• Focus on Infection Prevention: Antimicrobial catheters and other infection-prevention strategies gain importance as healthcare providers prioritize reducing urinary tract infections associated with catheter use.
• Telehealth Integration: Integration of telehealth services facilitates remote monitoring of catheterized patients, enhancing continuity of care and enabling timely intervention in case of complications.
• Sustainability Initiatives: Increasing awareness of environmental sustainability prompts manufacturers to explore eco-friendly materials and production methods for urinary catheters, aligning with broader healthcare sustainability goals.

Product Type Insights

In 2023, intermittent catheters emerged as the dominant segment, commanding over 56% of the market revenue. This trend is attributed to the lesser risk of urinary tract infections associated with intermittent catheterization compared to indwelling catheters, which are less commonly utilized due to their higher susceptibility to causing UTIs. Additionally, the widespread adoption of intermittent catheters is bolstered by their eligibility for reimbursement through Medicaid and Medicare programs, further driving their popularity in the market.

Looking ahead, external catheters are projected to experience the most rapid growth from 2024 to 2033. These catheters, worn externally, pose a reduced risk of urethral damage compared to intermittent catheters, making them increasingly favored. The escalating prevalence of urinary incontinence contributes to the segment's expansion, as external catheters are widely applicable in addressing such conditions. Furthermore, their noninvasive nature distinguishes them from other catheter types, further fueling their growth within the market.

Application Insights

In 2023, urinary incontinence emerged as the primary application for urinary catheters, representing nearly 39% of the total revenue generated. According to the National Association for Continence, approximately 25 million individuals in the U.S. suffer from some form of incontinence, with 75% to 80% of them being female. The prevalence of this condition has increased due to sedentary lifestyles and the aging population, resulting in a growing demand for urinary catheters to assist affected patients.

Benign prostatic hyperplasia (BPH) is another significant application driving the urinary catheters market, expected to experience the fastest growth in the forecast period. BPH, a common condition among older individuals, causes urinary retention primarily in men over the age of 50. Catheterization is utilized to alleviate bladder emptying difficulties associated with BPH. In severe cases, transurethral methods are employed, with approximately 150,000 men in the U.S. undergoing surgeries annually. The rising prevalence of BPH, coupled with the increasing demand for urinary retention treatment and growing awareness of its impact on quality of life, contribute to the expansion of the urinary catheters market.

U.S. Urinary Catheters Market Key Companies

• Hollister, Inc.
• Medtronic PLC
• Boston Scientific Corp.
• BD (C.R. Bard, Inc.)
• Cook Medical
• ConvaTec, Inc.
• Teleflex, Inc.
• Coloplast
• B. Braun Melsungen AG
• Medline Industries, Inc.
• J and M Urinary Catheters LLC
• Edwards Lifesciences Corporation
• Abbott Laboratories

Recent Developments

• In January 2024, Boston Scientific Corporation obtained FDA approval for the FARAPULSE™ Pulsed Field Ablation (PFA) System, presenting a groundbreaking alternative to traditional thermal ablation therapy for patients with drug-resistant, recurrent, symptomatic paroxysmal atrial fibrillation.
• In September 2023, Cook Medical forged a partnership with Bedal International, a specialist in catheter securement devices operating under the FlexGRIP brand. This collaboration introduced FlexGRIP devices into Cook’s range of percutaneous drainage products, expanding accessibility for Cook’s clientele across Europe, Canada, and the United States.
• In August 2023, Boston Scientific Corporation received FDA clearance for the POLARx™ Cryoablation System, which offers adjustable balloon sizes (28 and 31mm) within a single device, addressing limitations observed in previous cryoablation systems.

U.S. Urinary Catheters Market Segmentations:

By Product Type

• Intermittent Catheters
• Foley/Indwelling Catheters
• External Catheters

By Application

• Benign Prostate Hyperplasia
• Urinary Incontinence
• Spinal Cord Injury
• Others